All manufacturers Aburaihan Alchemia Pharma Alpha Pharma Anhui Anke Biotechnology Arcas Nutrition Axio Labs Balkan Pharmaceuticals Bayer Bio-Peptide Biochem Bioniche Pharma Bioreaktor Biosira BM Pharmaceuticals Body Research British Dispensary British Dragon Canada Peptides Centurion Laboratories Cooper Desma Diamond Dynamic Labs Eifelfango Euro PharmLabs Excel Pharma Galenika Gen Shi Lab GeneScience Genesis GEP Hilma Biocare Iran Hormone Jelfa Jinan Pharmaceuticals Kohoh Pharma Kubera Pharma Lilly Magnus Pharmaceuticals Malay Tiger Norma Nouveaux Novo Nordisk Novosarm Onyx Organon Pfizer Pharmacom Phoenix Primus Ray Lab QPharma Royal Pharma Sandoz Sci Pharma Tech Shree Venkatesh SIS Labs SP Labarotories Spectrum Pharma Sport Pharma Swiss Remedies Titan Vermodje West Pharm ZPHC
Either you respond to the specific points in this article – or – you choose to think with your glands. I’d prefer a debate on the facts, not your emotions. A number of years ago . Snow’s “The Two Cultures” was published warning of the dangers of scientific illiteracy. Read it, then take the trouble that the author of this article did, actually educate your self. That will not be easy. Slogans are easy, emotions are easy, intensions are easy. Admitting that you may have been wrong or mistaken is a sign of integrity. Self delusion is the hallmark of the intellectually bankrupt and I, for one, prefer to think and follow facts. A course I commend to you sir.
New Lower Strength of Auvi-Q Approved for Use in Young Children
Auvi-Q® (epinephrine injection) received FDA approval on November 20, 2017, to treat pediatric patients who weigh between ( pounds) and 25Kg (33 pounds). It is an auto-injector that delivers a smaller dose of epinephrine to block allergic reactions. Because it is designed for use in small children, the injector needle is shorter and the dose is smaller than in other Auvi-Q devices. The new injector has a voice feature that announces each step in the directions for use. Like Auvi-Q and 3mg auto-injectors, the lower dose will be dispensed in cartons containing two devices pre-filled with active drug and one inactive practice device. Detailed instructions are included with each prescription as well. Kaléo, Auvi-Q’s manufacturer, has not released its launch or pricing plans. Prescribing information can be found here .